← Back to Treatments
🏅 FDA Orphan Designation

Spinraza

NUSINERSEN

Manufacturer: Biogen Inc.

Indicated for:
Distal hereditary motor neuropathyOrphanSpinal Muscular AtrophyOrphan

FDA-Approved Indications (2)

Treatment of spinal muscular atrophy in pediatric and adult patients

Spinal Muscular AtrophyOrphan Designation

1 INDICATIONS AND USAGE SPINRAZA is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. SPINRAZA is a survival motor neuron-2 (SMN2)-directed antisense oligon…

Indications & Usage

1 INDICATIONS AND USAGE SPINRAZA is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. SPINRAZA is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients ( 1 )

💙 Support Programs

View all →
Spinraza
Biogen Inc.
Copay card ↗Apply ↗
Spinraza
Biogen
Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.